Leptin, defined as an adipose-derived hormone
Leptin is a hormone made mostly by fat cells (adipocytes) and secreted into the bloodstream, where it acts on receptors in the hypothalamus — the brain's metabolic command center. More body fat generally means more leptin; less body fat generally means less. Those signals influence appetite, thyroid tone, reproductive hormones, and resting energy expenditure. Leptin does not directly measure body fat percentage — it reflects adipocyte output, which correlates with fat mass but is not a body composition test.
How leptin signals energy availability to the brain
Leptin functions like a fuel gauge: when fat stores are adequate, leptin rises and the brain reads energy sufficiency; when stores fall, leptin drops and the brain responds by boosting appetite and quietly dialing down energy expenditure. Resting metabolism drifts lower, thyroid output can edge down, and reproductive signals may soften — survival biology in action. When leptin climbs with higher fat mass, appetite faces more resistance and energy burn ticks up slightly, though not enough to fully counter weight gain.
In many people with obesity, leptin is high yet the brain doesn't respond to it effectively. That's leptin resistance — a state where the satiety signal gets muffled, linked to brain inflammation and cellular stress. There is no single clinical test for leptin resistance. Leptin does not measure ghrelin, adiponectin, or hypothalamic receptor sensitivity directly.
Leptin also follows a circadian rhythm, rising overnight. Short sleep (around 4–5 hours) suppresses leptin and raises ghrelin, a combination associated with stronger cravings. Acute energy deficits can lower leptin within days, while real changes in fat mass drive the longer-term baseline. Higher leptin typically mirrors higher adiposity, which raises long-term risk for conditions like type 2 diabetes, fatty liver, sleep apnea, and cardiovascular disease. Chronically low leptin from underfueling can suppress reproductive signaling, thyroid tone, and bone remodeling over months to years.
Reading low, normal, and high leptin
Normal ranges
Reference ranges span widely and depend on sex, body composition, and the specific assay used. Typical fasting serum ranges are approximately 0.5–12.5 ng/mL in men and 1.1–27.5 ng/mL in women. Women typically have higher leptin than men at the same body fat level, partly due to differences in fat distribution and sex hormones. Assay methods vary across laboratories and are not always standardized, so results should be interpreted against the reference interval provided by the performing lab. A morning fasting sample reduces day-to-day noise and is the preferred draw condition. High leptin with persistent hunger may indicate leptin resistance rather than true energy surplus.
When levels run high
The most common reason for elevated leptin is higher total fat mass — fat cells make leptin, so more fat usually means more signal. If appetite remains strong despite high leptin, that pattern is consistent with leptin resistance, where the brain's satiety pathways respond weakly. This often travels with other metabolic signs such as higher fasting insulin, elevated triglycerides, or increased waist circumference.
Inflammation can push leptin up, as can hyperinsulinemia, since insulin stimulates leptin production in fat cells. Chronic kidney disease can elevate leptin because the kidneys help clear it. Pregnancy raises leptin through placental secretion. Certain medications that promote weight gain often track with higher leptin as a downstream effect.
When levels run low
Low leptin usually points to low fat mass or a recent energy deficit. Even a short stretch of hard training with fewer calories can pull leptin down and turn up hunger. Low leptin also appears in relative energy deficiency states, such as hypothalamic amenorrhea in athletes, where it correlates with reduced GnRH signaling, ovulatory disruption, and sometimes increased bone density risk. Rarely, genetic leptin deficiency causes extreme hyperphagia and very low circulating leptin in early life — specialist territory. A single low result is not a badge of success; if it comes with fatigue, cold intolerance, persistent hunger, or menstrual changes, that is actionable context for a clinician.
Why leptin tracks fat mass and energy balance
Adipose mass is the dominant driver of circulating leptin — it is the primary source of the hormone, so changes in fat mass are the strongest determinant of baseline levels. Several other factors can shift a leptin result meaningfully:
- Acute caloric deficit: leptin can drop within days of a large energy deficit, driving hunger and lethargy before any meaningful change in fat mass occurs.
- Carbohydrate reintroduction: reintroducing sufficient carbohydrates after a period of restriction raises leptin transiently, which helps explain the refeed effect studied in sports nutrition.
- Sleep restriction: limiting sleep to around 4–5 hours per night measurably suppresses leptin and raises ghrelin.
- Insulin and estrogen therapy: both tend to raise leptin as a consequence of their metabolic effects.
- Chronic kidney disease: impairs leptin clearance, elevating circulating levels independent of fat mass.
- Pregnancy: placental leptin production adds to circulating levels.
- Draw timing and assay type: a morning fasting sample is preferred; testing immediately after heavy training or sleep deprivation can acutely suppress leptin and would not reflect a stable baseline. Free and total leptin assays differ and are not interchangeable.
Leptin alongside metabolic and reproductive markers
Leptin's signal sharpens considerably when read alongside related biomarkers. The following tests are most informative in combination:
- Fasting insulin — fasting insulin and leptin are both elevated in insulin-resistance and leptin-resistance states; high insulin drives leptin production in fat cells, so the two together confirm the metabolic resistance pattern rather than a single-marker anomaly.
- Fasting glucose — contextualizes whether appetite dysregulation is driving or driven by glucose handling; a normal glucose with high leptin is the classic early insulin-resistance pattern.
- hs-CRP — systemic inflammation may impair hypothalamic leptin receptor signaling, amplifying leptin resistance; hs-CRP clarifies whether inflammatory disruption is contributing to the satiety-signal failure.
- TSH — hypothyroidism can influence weight and energy expenditure in ways that overlap with leptin dysfunction; TSH differentiates thyroid-driven from adipokine-driven metabolic signals.
- HbA1c — tracks average glucose and reflects chronic metabolic strain; in athletes with suspected relative energy deficiency (RED-S), low leptin combined with disrupted HbA1c and menstrual patterns defines the clinical picture more precisely than leptin alone.
A realistic retest window for leptin
Leptin tracks closely with adipose mass, which changes over 4–12 weeks with meaningful energy balance shifts. Acute caloric deficit can suppress leptin within days, but sustained changes in fat mass take 4–12 weeks to reflect in a stable fasting level. The standard retest interval when tracking a dietary or body composition change is 8–12 weeks.
Draw conditions matter for a valid comparison: use a morning fasting sample and avoid testing immediately after heavy training or a night of poor sleep, as both acutely suppress leptin and would not reflect a stable baseline. Use the same laboratory and the same morning fasting protocol across retests. Note that free and total leptin assays are not interchangeable — confirm the assay type is consistent between draws before comparing values.
When leptin warrants a metabolic workup
Leptin testing adds the most clarity in specific situations. If weight loss stalls despite consistent habits, a low leptin reading may explain stronger hunger and slower energy burn during that phase — physiology doing its job, not a failure of effort. If appetite feels high despite elevated leptin, that pattern aligns with leptin resistance and shifts the focus toward signal quality rather than simply reducing calories further.
In athletes with menstrual disruption or recurrent stress fractures, low leptin can be a key piece of the low-energy-availability puzzle. In chronic kidney disease or during pregnancy, it helps separate physiologic shifts from pathology. Most of all, measuring and trending leptin over time — alongside sleep, training load, and related biomarkers — turns guesswork into feedback.
A comprehensive biomarker panel stitches the whole story together: appetite signals, metabolic response, inflammation, and hormone crosstalk. Leptin is the narrator of energy status, but its voice makes sense in a chorus with insulin, hs-CRP, TSH, HbA1c, and fasting glucose. With clear data and thoughtful interpretation from qualified professionals, patterns become actionable. That's the approach behind Superpower and the thinking outlined in our manifesto: using your numbers to build a body that adapts, recovers, and performs on your terms.
FAQs
References
- Spiegel, K., Tasali, E., Penev, P., & Van Cauter, E. (2004). Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of internal medicine, 141(11), 846-50. https://doi.org/10.7326/0003-4819-141-11-200412070-00008
- Varkaneh Kord, H., M Tinsley, G., O Santos, H., Zand, H., Nazary, A., Fatahi, S., Mokhtari, Z., Salehi-Sahlabadi, A., Tan, S. C., Rahmani, J., Gaman, M. A., Sathian, B., Sadeghi, A., Hatami, B., Soltanieh, S., Aghamiri, S., Bawadi, H., & Hekmatdoost, A. (2021). The influence of fasting and energy-restricted diets on leptin and adiponectin levels in humans: A systematic review and meta-analysis. Clinical nutrition, 40(4), 1811-1821. https://doi.org/10.1016/j.clnu.2020.10.034
- Perakakis, N., & Mantzoros, C. S. (2024). Evidence from clinical studies of leptin: current and future clinical applications in humans. Metabolism: clinical and experimental, 161, 156053. https://doi.org/10.1016/j.metabol.2024.156053
- Welt, C. K., Chan, J. L., Bullen, J., Murphy, R., Smith, P., DePaoli, A. M., Karalis, A., & Mantzoros, C. S. (2004). Recombinant human leptin in women with hypothalamic amenorrhea. The New England journal of medicine, 351(10), 987-97. https://doi.org/10.1056/NEJMoa040388
- Vilariño-García, T., Polonio-González, M. L., Pérez-Pérez, A., Ribalta, J., Arrieta, F., Aguilar, M., Obaya, J. C., Gimeno-Orna, J. A., Iglesias, P., Navarro, J., Durán, S., Pedro-Botet, J., & Sánchez-Margalet, V. (2024). Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes. International journal of molecular sciences, 25(4). https://doi.org/10.3390/ijms25042338






































.avif)
